Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
16.61
+0.31 (1.90%)
Nov 13, 2026, 4:00 PM EST - Market closed
Sotera Health Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,230 | 1,164 | 1,100 | 1,049 | 1,004 | 931.48 | |
Revenue Growth | 6.90% | 5.74% | 4.88% | 4.54% | 7.75% | 13.85% |
Cost of Revenue | 558.01 | 518.08 | 498.15 | 472.13 | 446.68 | 412.81 |
Gross Profit | 671.74 | 645.53 | 602.3 | 577.16 | 557 | 518.67 |
Selling, General & Admin | 207.63 | 200.46 | 204.75 | 186.37 | 166.18 | 149.36 |
Amortization of Goodwill & Intangibles | 12.07 | 30.74 | 62.04 | 63.8 | 62.94 | 63.78 |
Operating Expenses | 219.7 | 231.2 | 266.79 | 250.16 | 229.12 | 213.14 |
Operating Income | 452.04 | 414.33 | 335.51 | 326.99 | 327.89 | 305.53 |
Interest Expense | -138.32 | -155.72 | -164.69 | -142.88 | -80.14 | -74.19 |
Currency Exchange Gain (Loss) | 3.85 | -0.95 | -0.2 | -0.16 | -0.15 | -1.35 |
Other Non Operating Income (Expenses) | 2.12 | 2.47 | 0.12 | 2.38 | -0.46 | 3.56 |
EBT Excluding Unusual Items | 319.69 | 260.14 | 170.74 | 186.34 | 247.14 | 233.55 |
Gain (Loss) on Sale of Investments | - | - | - | - | -9.61 | - |
Legal Settlements | -43.57 | -111.17 | -32.69 | -80.31 | -480.64 | -45.66 |
Other Unusual Items | -1.23 | -1.46 | -24.17 | - | - | -15.58 |
Pretax Income | 274.89 | 147.51 | 113.87 | 106.03 | -243.11 | 175.72 |
Income Tax Expense | 101.42 | 69.56 | 69.48 | 54.65 | -9.54 | 58.6 |
Earnings From Continuing Operations | 173.47 | 77.95 | 44.4 | 51.38 | -233.57 | 117.12 |
Minority Interest in Earnings | - | - | - | - | - | -0.24 |
Net Income | 173.47 | 77.95 | 44.4 | 51.38 | -233.57 | 116.88 |
Preferred Dividends & Other Adjustments | 0 | 0 | 0.06 | 0.29 | - | 1.52 |
Net Income to Common | 173.47 | 77.95 | 44.34 | 51.09 | -233.57 | 115.36 |
Net Income Growth | 213.03% | 75.79% | -13.21% | - | - | - |
Shares Outstanding (Basic) | 285 | 284 | 283 | 281 | 280 | 279 |
Shares Outstanding (Diluted) | 288 | 286 | 285 | 283 | 280 | 279 |
Shares Change | 0.76% | 0.53% | 0.60% | 1.12% | 0.26% | 17.54% |
EPS (Basic) | 0.61 | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 |
EPS (Diluted) | 0.60 | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 |
EPS Growth | 207.06% | 72.20% | -12.89% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 135.43 | 149.18 | 45.09 | -362.71 | 95.58 | 179.38 |
Free Cash Flow Per Share | 0.47 | 0.52 | 0.16 | -1.28 | 0.34 | 0.64 |
Gross Margin | 54.62% | 55.48% | 54.73% | 55.01% | 55.50% | 55.68% |
Operating Margin | 36.76% | 35.61% | 30.49% | 31.16% | 32.67% | 32.80% |
Profit Margin | 14.11% | 6.70% | 4.03% | 4.87% | -23.27% | 12.38% |
Free Cash Flow Margin | 11.01% | 12.82% | 4.10% | -34.57% | 9.52% | 19.26% |
EBITDA | 583.82 | 553.36 | 501.78 | 487.33 | 475.63 | 458.68 |
EBITDA Margin | 47.48% | 47.55% | 45.60% | 46.44% | 47.39% | 49.24% |
D&A For EBITDA | 131.78 | 139.03 | 166.28 | 160.34 | 147.75 | 153.15 |
EBIT | 452.04 | 414.33 | 335.51 | 326.99 | 327.89 | 305.53 |
EBIT Margin | 36.76% | 35.61% | 30.49% | 31.16% | 32.67% | 32.80% |
Effective Tax Rate | 36.90% | 47.16% | 61.01% | 51.54% | - | 33.35% |
Revenue as Reported | 1,230 | 1,164 | 1,100 | 1,049 | 1,004 | 931.48 |